Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Revenues $ 0 $ 0 $ 50,000 $ 0
Costs and Expenses        
Operating expenses 535,000 467,000 2,373,000 1,728,000
Research and development expenses 53,000 52,000 173,000 200,000
Loss before other expenses (588,000) (519,000) (2,496,000) (1,928,000)
Other income (expenses)        
Interest and financing expense (227,000) (516,000) (1,649,000) (1,449,000)
Loss on disposition of equipment 0 0 0 (3,000)
Net loss $ (815,000) $ (1,035,000) $ (4,145,000) $ (3,380,000)
Net loss per common share, basic and diluted $ (0.00) $ (0.01) $ (0.02) $ (0.02)
Weighted average common shares outstanding, basic and diluted 230,132,723 198,343,504 212,384,061 190,874,796